News
Rein Therapeutics CEO and president Brian Windsor said: "We are taking the evaluation of biomarkers a step further with the application of cutting-edge deep-learning imaging technology and ...
The article was authored by BreAnne MacKenzie, Ph.D., Director of Translational Research, Cory M. Hogaboam, Ph.D., Chief Scientific Officer, and Brian Windsor, Ph.D., President and Chief Executive ...
Hosted on MSN6mon
Rodman & Renshaw sets $8 target for Rein Therapeutics stockThe company's shareholders elected Brian Windsor and Alan A. Musso as Class I directors, and Marcum LLP was ratified as the independent registered public accounting firm for the fiscal year ending ...
Brian Windsor, President and CEO, said, "The rebrand to Rein Therapeutics represents our unwavering commitment to advancing novel therapies for fibrotic diseases." ...
What should I know about this advisor? Brian Windsor is a financial advisor in McLean, VA, and have earned their CFP. They have been in practice for 14 years, the last 2 years at Bogart Wealth LLC.
Cash, cash equivalents, and investments on December 31, 2024, were $12.9M, compared to $17.3M on December 31, 2023. “We’ve made significant clinical progress during 2024, culminating in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results